BRISTOL-MYERS SQUIBB COMPANY Other Restructuring Costs
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Restructuring Costs of $2.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-04-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2023-04-27
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for the quarter ending 2023-03-31 was $2.00M, a 100.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for the quarter ending 2022-12-31 was $3.00M, a 0.00% change year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for the quarter ending 2022-09-30 was $1.00M, a 66.67% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for the quarter ending 2022-06-30 was $1.00M, a 66.67% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for fiscal 2022 was $6.00M, a 40.00% decline from fiscal 2021.
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for fiscal 2021 was $10.00M, a 86.30% decline from fiscal 2020.
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for fiscal 2020 was $73.00M, a 160.71% increase from fiscal 2019.
- BRISTOL-MYERS SQUIBB COMPANY other restructuring costs for fiscal 2019 was $28.00M, a 36.36% decline from fiscal 2018.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month | Other Restructuring Costs 12 month |
|---|---|---|---|---|
| 2023-03-31 | $2.00M 10-Q · filed 2023-04-27 | $5.00M derived: sum of 2 quarters · filed 2023-04-27 | $6.00M derived: sum of 3 quarters · filed 2023-04-27 | $7.00M derived: sum of 4 quarters · filed 2023-04-27 |
| 2022-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $4.00M derived: sum of 2 quarters · filed 2023-02-14 | $5.00M derived: sum of 3 quarters · filed 2023-02-14 | $6.00M 10-K · filed 2023-02-14 |
| 2022-09-30 | $1.00M 10-Q · filed 2022-10-26 | $2.00M derived: sum of 2 quarters · filed 2022-10-26 | $3.00M 10-Q · filed 2022-10-26 | $6.00M derived: sum of 4 quarters · filed 2023-04-27 |
| 2022-06-30 | $1.00M 10-Q · filed 2022-07-27 | $2.00M 10-Q · filed 2022-07-27 | $5.00M derived: sum of 3 quarters · filed 2023-04-27 | $8.00M derived: sum of 4 quarters · filed 2023-04-27 |
| 2022-03-31 | $1.00M 10-Q · filed 2023-04-27 | $4.00M derived: sum of 2 quarters · filed 2023-04-27 | $7.00M derived: sum of 3 quarters · filed 2023-04-27 | $10.00M derived: sum of 4 quarters · filed 2023-04-27 |
| 2021-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $6.00M derived: sum of 2 quarters · filed 2023-02-14 | $9.00M derived: sum of 3 quarters · filed 2023-02-14 | $10.00M 10-K · filed 2023-02-14 |
| 2021-09-30 | $3.00M 10-Q · filed 2022-10-26 | $6.00M derived: sum of 2 quarters · filed 2022-10-26 | $7.00M 10-Q · filed 2022-10-26 | $18.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $3.00M 10-Q · filed 2022-07-27 | $4.00M 10-Q · filed 2022-07-27 | $15.00M derived: sum of 3 quarters · filed 2023-02-14 | $58.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $1.00M 10-Q · filed 2022-04-29 | $12.00M derived: sum of 2 quarters · filed 2023-02-14 | $55.00M derived: sum of 3 quarters · filed 2023-02-14 | $63.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $54.00M derived: sum of 2 quarters · filed 2023-02-14 | $62.00M derived: sum of 3 quarters · filed 2023-02-14 | $73.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $43.00M 10-Q · filed 2021-10-27 | $51.00M derived: sum of 2 quarters · filed 2021-10-27 | $62.00M 10-Q · filed 2021-10-27 | $69.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $8.00M 10-Q · filed 2021-07-28 | $19.00M 10-Q · filed 2021-07-28 | $26.00M derived: sum of 3 quarters · filed 2022-02-09 | $32.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $11.00M 10-Q · filed 2021-04-29 | $18.00M derived: sum of 2 quarters · filed 2022-02-09 | $24.00M derived: sum of 3 quarters · filed 2022-02-09 | $31.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $13.00M derived: sum of 2 quarters · filed 2022-02-09 | $20.00M derived: sum of 3 quarters · filed 2022-02-09 | $28.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $6.00M 10-Q · filed 2019-10-31 | $13.00M derived: sum of 2 quarters · filed 2019-10-31 | $21.00M 10-Q · filed 2019-10-31 | $35.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $7.00M 10-Q · filed 2019-07-25 | $15.00M 10-Q · filed 2019-07-25 | $29.00M derived: sum of 3 quarters · filed 2021-02-10 | $37.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $8.00M 10-Q · filed 2019-04-25 | $22.00M derived: sum of 2 quarters · filed 2021-02-10 | $30.00M derived: sum of 3 quarters · filed 2021-02-10 | $41.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $22.00M derived: sum of 2 quarters · filed 2021-02-10 | $33.00M derived: sum of 3 quarters · filed 2021-02-10 | $44.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $8.00M 10-Q · filed 2019-10-31 | $19.00M derived: sum of 2 quarters · filed 2019-10-31 | $30.00M 10-Q · filed 2019-10-31 | $39.00M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $11.00M 10-Q · filed 2019-07-25 | $22.00M 10-Q · filed 2019-07-25 | $31.00M derived: sum of 3 quarters · filed 2019-07-25 | $41.00M derived: sum of 4 quarters · filed 2019-07-25 |
| 2018-03-31 | $11.00M 10-Q · filed 2019-04-25 | $20.00M derived: sum of 2 quarters · filed 2019-04-25 | $30.00M derived: sum of 3 quarters · filed 2019-04-25 | $34.00M derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $19.00M derived: sum of 2 quarters · filed 2019-02-25 | $23.00M derived: sum of 3 quarters · filed 2019-02-25 | $26.00M 10-K · filed 2019-02-25 |
| 2017-09-30 | $10.00M 10-Q · filed 2017-10-26 | $14.00M derived: sum of 2 quarters · filed 2017-10-26 | $17.00M 10-Q · filed 2017-10-26 | $20.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $4.00M 10-Q · filed 2017-07-27 | $7.00M 10-Q · filed 2017-07-27 | $10.00M derived: sum of 3 quarters · filed 2019-02-25 | $12.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $3.00M 10-Q · filed 2017-04-27 | $6.00M derived: sum of 2 quarters · filed 2019-02-25 | $8.00M derived: sum of 3 quarters · filed 2019-02-25 | $15.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $5.00M derived: sum of 2 quarters · filed 2019-02-25 | $12.00M derived: sum of 3 quarters · filed 2019-02-25 | $12.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $2.00M 10-Q · filed 2017-10-26 | $9.00M derived: sum of 2 quarters · filed 2017-10-26 | $9.00M 10-Q · filed 2017-10-26 | |
| 2016-06-30 | $7.00M 10-Q · filed 2017-07-27 | $7.00M 10-Q · filed 2017-07-27 | ||
| 2015-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $4.00M derived: sum of 2 quarters · filed 2018-02-13 | $6.00M derived: sum of 3 quarters · filed 2018-02-13 | $8.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $1.00M 10-Q · filed 2015-10-27 | $3.00M derived: sum of 2 quarters · filed 2015-10-27 | $5.00M 10-Q · filed 2015-10-27 | $7.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $2.00M 10-Q · filed 2015-07-23 | $4.00M 10-Q · filed 2015-07-23 | $6.00M derived: sum of 3 quarters · filed 2017-02-21 | $7.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $2.00M 10-Q · filed 2015-04-28 | $4.00M derived: sum of 2 quarters · filed 2017-02-21 | $5.00M derived: sum of 3 quarters · filed 2017-02-21 | $7.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $3.00M derived: sum of 2 quarters · filed 2017-02-21 | $5.00M derived: sum of 3 quarters · filed 2017-02-21 | $6.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $1.00M 10-Q · filed 2015-10-27 | $3.00M derived: sum of 2 quarters · filed 2015-10-27 | $4.00M 10-Q · filed 2015-10-27 | $12.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $2.00M 10-Q · filed 2015-07-23 | $3.00M 10-Q · filed 2015-07-23 | $11.00M derived: sum of 3 quarters · filed 2016-02-12 | $13.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $1.00M 10-Q · filed 2015-04-28 | $9.00M derived: sum of 2 quarters · filed 2016-02-12 | $11.00M derived: sum of 3 quarters · filed 2016-02-12 | $12.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $10.00M derived: sum of 2 quarters · filed 2016-02-12 | $11.00M derived: sum of 3 quarters · filed 2016-02-12 | $15.00M 10-K · filed 2016-02-12 |
| 2013-09-30 | $2.00M 10-Q · filed 2014-10-24 | $3.00M derived: sum of 2 quarters · filed 2014-10-24 | $7.00M 10-Q · filed 2014-10-24 | $21.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $1.00M 10-Q · filed 2014-07-24 | $5.00M 10-Q · filed 2014-07-24 | $19.00M derived: sum of 3 quarters · filed 2015-02-13 | $27.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $4.00M 10-Q · filed 2014-04-29 | $18.00M derived: sum of 2 quarters · filed 2015-02-13 | $26.00M derived: sum of 3 quarters · filed 2015-02-13 | $30.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $22.00M derived: sum of 2 quarters · filed 2015-02-13 | $26.00M derived: sum of 3 quarters · filed 2015-02-13 | $29.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | $8.00M 10-Q · filed 2013-10-23 | $12.00M derived: sum of 2 quarters · filed 2013-10-23 | $15.00M 10-Q · filed 2013-10-23 | $26.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $4.00M 10-Q · filed 2013-07-25 | $7.00M 10-Q · filed 2013-07-25 | $18.00M derived: sum of 3 quarters · filed 2014-02-14 | $22.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $3.00M 10-Q · filed 2013-04-25 | $14.00M derived: sum of 2 quarters · filed 2014-02-14 | $18.00M derived: sum of 3 quarters · filed 2014-02-14 | $33.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $15.00M derived: sum of 2 quarters · filed 2014-02-14 | $30.00M derived: sum of 3 quarters · filed 2014-02-14 | $31.00M 10-K · filed 2014-02-14 |
| 2011-09-30 | $4.00M 10-Q · filed 2012-10-24 | $19.00M derived: sum of 2 quarters · filed 2012-10-24 | $20.00M 10-Q · filed 2012-10-24 | $21.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $15.00M 10-Q · filed 2012-07-25 | $16.00M 10-Q · filed 2012-07-25 | $17.00M derived: sum of 3 quarters · filed 2013-02-15 | $29.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $1.00M 10-Q · filed 2012-04-26 | $2.00M derived: sum of 2 quarters · filed 2013-02-15 | $14.00M derived: sum of 3 quarters · filed 2013-02-15 | $11.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $13.00M derived: sum of 2 quarters · filed 2013-02-15 | $10.00M derived: sum of 3 quarters · filed 2013-02-15 | $11.00M 10-K · filed 2013-02-15 |
| 2010-09-30 | $12.00M 10-Q · filed 2011-10-27 | $9.00M derived: sum of 2 quarters · filed 2011-10-27 | $10.00M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | -$3.00M 10-Q · filed 2011-07-28 | -$2.00M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $1.00M 10-Q · filed 2011-04-28 | |||
| 2009-12-31 | $8.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |